S Bregenholt

MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis

Søren Skov, S Bregenholt, Mogens H. Claësson · The Journal of Immunology · 1997 · 77 citations

Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions

S Bregenholt, Søren Skov, M H Claësson · The Journal of Immunology · 1996 · 45 citations

Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes

Jacob Petersen, S Bregenholt, V APOSTOLOPOLOUS et al. · Clinical & Experimental Immunology · 2003 · 41 citations · Full text

Class Ii, Autoimmune Disease, Biochemistry +14

The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes

S Bregenholt, M. Wang, T. Wolfe et al. · Scandinavian Journal of Immunology · 2003 · 36 citations

Immunology, Immunotherapy, Mucosal Adjuvant +22

GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development

Lisbeth B. Knudsen, Christina Bjenning, S Bregenholt et al. · Drugs of the Future · 2001 · 35 citations

Glp-1 Derivatives, Diabetes Management, Medicine +7